retatrutide and tesamorelin The + Stack: Full Protocol & Results 8 Weeks on Retatrutide, BHRT
Description
We think thats a signal worth investigating, says Neil Sehgal, the studys first author and a doctoral student in CIS at the University of Pennsylvania
Dizziness is reported by some patients taking GLP-1 receptor agonists like Ozempic, though it is not listed as a primary side effect in clinical trials
Ozempic was approved for sale in the US in 2017 and Europe in 2018
Although GLP-1RAs can play a favorable role in improving heart failure based on pre-clinical studies, whereas some clinical evidence relevantly have reported that GLP-1RAs treatment could be associated with adverse heart failure events, eg
